Skip to main content
Gabather AB logo

Gabather AB — Investor Relations & Filings

Ticker · GABA ISIN · SE0010869552 LEI · 549300VLUOMD0TE1O093 ST Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST GABA

About Gabather AB

https://gabather.com/

Gabather AB is a pharmaceutical company developing next-generation therapeutics for neuropsychiatric and other Central Nervous System (CNS) disorders. The company's approach focuses on restoring brain balance by targeting the GABAA receptor system. Its proprietary drug candidates aim to enhance cognitive function. The lead candidate, GT-002, has completed Phase I clinical trials, demonstrating a favorable safety and tolerability profile. Gabather's development program targets major unmet medical needs across four key areas: anti-psychotics, anti-depressants/anxiolytics, analgesics, and cognition-enhancing treatments for conditions such as Schizophrenia and Alzheimer's disease.

Recent filings

No filings indexed yet

We are still gathering filings for Gabather AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.